1st Line Durvalumab in PS 2 NSCLC Patients
1st Line Durvalumab in PS 2 NSCLC Patients
Active, not recruiting · NCT03620669 · Registry updated 2025-08-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 1st Line Durvalumab in PS 2 NSCLC Patients | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2025-08-15 | NCT03620669 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Swiss Cancer Institute | 29 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hopital Fribourgeois HFR | Fribourg | Switzerland | 2 |
| Hôpitaux universitaires de Genève | Geneva | Switzerland | 11 |
| Inselspital | Bern | Switzerland | 24 |
| IOSI Ospedale Regionale di Bellinzona e Valli | Bellinzona | Switzerland | 5 |
| Kantonsspital - St. Gallen | Sankt Gallen | Switzerland | 7 |
| Kantonsspital Aarau | Aarau | Switzerland | 7 |
| Kantonsspital Baden | Baden | Switzerland | 29 |
| Kantonsspital Graubuenden | Chur | Switzerland | 7 |
| Kantonsspital Winterthur | Winterthur | Switzerland | 1 |
| Spital STS AG | Thun | Switzerland | 5 |
| Universitaetsspital Basel | Basel | Switzerland | 18 |